Cargando…

Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China

PURPOSE: To investigate the effects of ICU quality control indicators on the VAP incidence rate and mortality in China throughout 2019. METHODS: This was a retrospective study. A total of 1267 ICUs from 30 provinces in mainland China were included. Data were collected using the National Clinical Imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Xin, Ma, Xudong, Gao, Sifa, Su, Longxiang, Shan, Guangliang, Hu, Yaoda, Chen, Jieqing, Ma, Dandan, Zhang, Feng, Zhu, Wen, Sun, Guoqiang, Meng, Xiaoyang, Ma, Lian, Zhou, Xiang, Liu, Dawei, Du, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798551/
https://www.ncbi.nlm.nih.gov/pubmed/36581952
http://dx.doi.org/10.1186/s13054-022-04285-6
_version_ 1784860928085327872
author Ding, Xin
Ma, Xudong
Gao, Sifa
Su, Longxiang
Shan, Guangliang
Hu, Yaoda
Chen, Jieqing
Ma, Dandan
Zhang, Feng
Zhu, Wen
Sun, Guoqiang
Meng, Xiaoyang
Ma, Lian
Zhou, Xiang
Liu, Dawei
Du, Bin
author_facet Ding, Xin
Ma, Xudong
Gao, Sifa
Su, Longxiang
Shan, Guangliang
Hu, Yaoda
Chen, Jieqing
Ma, Dandan
Zhang, Feng
Zhu, Wen
Sun, Guoqiang
Meng, Xiaoyang
Ma, Lian
Zhou, Xiang
Liu, Dawei
Du, Bin
author_sort Ding, Xin
collection PubMed
description PURPOSE: To investigate the effects of ICU quality control indicators on the VAP incidence rate and mortality in China throughout 2019. METHODS: This was a retrospective study. A total of 1267 ICUs from 30 provinces in mainland China were included. Data were collected using the National Clinical Improvement System Data that report ICU information. Ten related quality control indicators were analyzed, including 5 structural factors (patient-to-bed ratio, physician-to-bed ratio, nurse-to-bed ratio, patient-to-physician ratio, and patient-to-nurse ratio), 3 process factors (unplanned endotracheal extubation rate, reintubation rate within 48 h, and microbiology detection rate before antibiotic use), and 2 outcome factors (VAP incidence rate and mortality). The information on the most common infectious pathogens and the most commonly used antibiotics in ICU was also collected. The Poisson regression model was used to identify the impact of factors on the incidence rate and mortality of VAP. RESULTS: The incidence rate of VAP in these hospitals in 2019 was 5.03 (2.38, 10.25) per 1000 ventilator days, and the mortality of VAP was 11.11 (0.32, 26.00) %. The most common causative pathogen was Acinetobacter baumannii (in 39.98% of hospitals), followed by Klebsiella pneumoniae (38.26%), Pseudomonas aeruginosa, and Escherichia coli. In 26.90% of hospitals, third-generation cephalosporin was the most used antibiotic, followed by carbapenem (24.22%), penicillin and beta-lactamase inhibitor combination (20.09%), cephalosporin with beta-lactamase inhibitor (17.93%). All the structural factors were significantly associated with VAP incidence rate, but not with the mortality, although the trend was inconsistent. Process factors including unplanned endotracheal extubation rate, reintubation rate in 48 h, and microbiology detection rate before antibiotic use were associated with higher VAP mortality, while unplanned endotracheal extubation rate and reintubation rate in 48 h were associated with higher VAP mortality. Furthermore, K. pneumoniae as the most common pathogen was associated with higher VAP mortality, and carbapenems as the most used antibiotics were associated with lower VAP mortality. CONCLUSION: This study highlights the association between the ICU quality control (QC) factors and VAP incidence rate and mortality. The process factors rather than the structural factors need to be further improved for the QC of VAP in the ICU. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-022-04285-6.
format Online
Article
Text
id pubmed-9798551
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97985512022-12-30 Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China Ding, Xin Ma, Xudong Gao, Sifa Su, Longxiang Shan, Guangliang Hu, Yaoda Chen, Jieqing Ma, Dandan Zhang, Feng Zhu, Wen Sun, Guoqiang Meng, Xiaoyang Ma, Lian Zhou, Xiang Liu, Dawei Du, Bin Crit Care Research PURPOSE: To investigate the effects of ICU quality control indicators on the VAP incidence rate and mortality in China throughout 2019. METHODS: This was a retrospective study. A total of 1267 ICUs from 30 provinces in mainland China were included. Data were collected using the National Clinical Improvement System Data that report ICU information. Ten related quality control indicators were analyzed, including 5 structural factors (patient-to-bed ratio, physician-to-bed ratio, nurse-to-bed ratio, patient-to-physician ratio, and patient-to-nurse ratio), 3 process factors (unplanned endotracheal extubation rate, reintubation rate within 48 h, and microbiology detection rate before antibiotic use), and 2 outcome factors (VAP incidence rate and mortality). The information on the most common infectious pathogens and the most commonly used antibiotics in ICU was also collected. The Poisson regression model was used to identify the impact of factors on the incidence rate and mortality of VAP. RESULTS: The incidence rate of VAP in these hospitals in 2019 was 5.03 (2.38, 10.25) per 1000 ventilator days, and the mortality of VAP was 11.11 (0.32, 26.00) %. The most common causative pathogen was Acinetobacter baumannii (in 39.98% of hospitals), followed by Klebsiella pneumoniae (38.26%), Pseudomonas aeruginosa, and Escherichia coli. In 26.90% of hospitals, third-generation cephalosporin was the most used antibiotic, followed by carbapenem (24.22%), penicillin and beta-lactamase inhibitor combination (20.09%), cephalosporin with beta-lactamase inhibitor (17.93%). All the structural factors were significantly associated with VAP incidence rate, but not with the mortality, although the trend was inconsistent. Process factors including unplanned endotracheal extubation rate, reintubation rate in 48 h, and microbiology detection rate before antibiotic use were associated with higher VAP mortality, while unplanned endotracheal extubation rate and reintubation rate in 48 h were associated with higher VAP mortality. Furthermore, K. pneumoniae as the most common pathogen was associated with higher VAP mortality, and carbapenems as the most used antibiotics were associated with lower VAP mortality. CONCLUSION: This study highlights the association between the ICU quality control (QC) factors and VAP incidence rate and mortality. The process factors rather than the structural factors need to be further improved for the QC of VAP in the ICU. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-022-04285-6. BioMed Central 2022-12-29 /pmc/articles/PMC9798551/ /pubmed/36581952 http://dx.doi.org/10.1186/s13054-022-04285-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ding, Xin
Ma, Xudong
Gao, Sifa
Su, Longxiang
Shan, Guangliang
Hu, Yaoda
Chen, Jieqing
Ma, Dandan
Zhang, Feng
Zhu, Wen
Sun, Guoqiang
Meng, Xiaoyang
Ma, Lian
Zhou, Xiang
Liu, Dawei
Du, Bin
Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China
title Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China
title_full Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China
title_fullStr Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China
title_full_unstemmed Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China
title_short Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China
title_sort effect of icu quality control indicators on vap incidence rate and mortality: a retrospective study of 1267 hospitals in china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798551/
https://www.ncbi.nlm.nih.gov/pubmed/36581952
http://dx.doi.org/10.1186/s13054-022-04285-6
work_keys_str_mv AT dingxin effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT maxudong effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT gaosifa effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT sulongxiang effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT shanguangliang effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT huyaoda effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT chenjieqing effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT madandan effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT zhangfeng effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT zhuwen effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT sunguoqiang effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT mengxiaoyang effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT malian effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT zhouxiang effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT liudawei effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT dubin effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina
AT effectoficuqualitycontrolindicatorsonvapincidencerateandmortalityaretrospectivestudyof1267hospitalsinchina